IL-24 confers antitumor activity by several processes, including the inhibition of cellular migration and invasion, as observed in LC cells, an effect accompanied by the downregulation of markers such as pJNK, p38MAPK, pFAK, and MMP-2/9, associated with migration and invasion. This evidence concerns the gene IL24 and laryngotracheoesophageal cleft.